NDC 51429-010 - Neo-Oxy 100/100 MR
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51429-010
- Package NDCs from labels
- 51429-010-03
- Manufacturer
- Pharmgate Animal Health | Pharmgate Inc.
- Effective date
- 2026-01-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Neo-Oxy 100/100 MR ® | Pharmgate Animal Health | Pharmgate Inc. | 2026-01-07 | VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51429-010-03 | Neo-Oxy 100/100 MR | 22.68 kg in 1 DRUM | POWDER | 22.68 | 6 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Neomycin Sulfate | ACTIVE INGREDIENT | 057Y626693 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Hydrochloride | ACTIVE INGREDIENT | 4U7K4N52ZM | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Neomycin | ACTIVE MOIETY | I16QD7X297 | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 | |
| Oxytetracycline Anhydrous | ACTIVE MOIETY | SLF0D9077S | NEO-OXY 100/100 MR (OXYTETRACYCLINE HYDROCHLORIDE AND NEOMYCIN SULFATE) POWDER [PHARMGATE ANIMAL HEALTH] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE , POLYMYXIN B SULFATE. | TRIFECTA PHARMACEUTICALS USA LLC | 4124e9e2-397f-8921-e063-6394a90a5ffe | 2025-10-14 | Warnings | 057Y626693 |
| Neomycin and Polymyxin B Sulfates and Hydrocortisone | NEOMYCIN SULFATE, POLYMYXIN B SULFATE, HYDROCORTISONE | Bausch & Lomb Incoporated | 986e5b75-39fc-480f-9026-191b2d15dea1 | 2025-10-13 | Warnings, Adverse reactions | 057Y626693 |
| Antibiotic | NEOMYCIN SULFATE | Total Resources International | 0725364b-b243-4891-af2f-a6049366d038 | 2025-10-10 | Warnings | 057Y626693 |
| MediChoice Triple Antibiotic | BACITRACIN | O&M HALYARD, INC. | 8369f399-6f64-4441-be72-1f16c7306c0a | 2025-10-09 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Medline Industries, LP | 301ebb9a-033b-4f04-99ff-571e921924ca | 2025-10-09 | Warnings | 057Y626693 |
| NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE | Amneal Pharmaceuticals NY LLC | bea0457d-40a7-4af9-ac77-b04235680176 | 2025-10-06 | Warnings, Adverse reactions | 057Y626693 |
| Neomycin Sulfate | NEOMYCIN SULFATE | Solaris Pharma Corporation | f430c5d9-ae82-3314-e053-2a95a90af04c | 2025-10-03 | Boxed warning, Warnings, Adverse reactions | 057Y626693 |
| TheraCare Triple Antibiotic Pain Relief | BACITRACIN,NEOMYCIN,POLYMXIN, PRAMOXINE | Veridian Healthcare | faf73908-324f-27f5-e053-6394a90aa06e | 2025-10-02 | Warnings | 057Y626693 |
| Good Sense First Aid Antibiotic | BACITRACIN ZINC, NEOMYCIN, POLYMYXIN B | Preferred Pharmaceuticals Inc. | ac5b585c-050d-44a2-80d2-642597dc8892 | 2025-10-01 | Warnings | 057Y626693 |
| Xpect Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Cintas Corporation | 39355db3-24d7-485f-9ce0-f0e466e96593 | 2025-09-26 | Warnings | 057Y626693 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE PRAMOXINE HCL | Encube Ethicals, Inc. | dfea6b2e-cd76-439d-a3da-64e2d8717163 | 2025-09-25 | Warnings | 057Y626693 |
| TRIPLE ANTIBIOTIC | BACITRACIN ZINC NEOMYCIN SULFATE POLYMYXIN B SULFATE | Encube Ethicals, Inc. | 2e985ad0-aa50-4c6b-b0af-1d61489a9fda | 2025-09-25 | Warnings | 057Y626693 |
| Medi-First Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | f2f0a1da-3e33-3c1a-e053-2a95a90a12b1 | 2025-09-09 | Warnings | 057Y626693 |
| Ecolab Triple Antibiotic | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Ecolabs Food Safety Specialties, Inc. | 4aef8f98-db76-07f2-e054-00144ff8d46c | 2025-09-09 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d265f094-e654-4c68-9215-b5d061af885d | 2025-09-08 | Warnings | 057Y626693 |
| Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Unifirst First Aid Corporation | d7c1a10e-c38d-4ae8-9a27-c07c2208ca84 | 2025-09-08 | Warnings | 057Y626693 |
| Thompson Triple Antibiotic | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Thompson | f883c4cb-c32c-76e3-e053-6294a90aa4fc | 2025-09-08 | Warnings | 057Y626693 |
| Thompson Triple Antibiotic | BACITRACIN ZINC, POLYMYXIN B SULFATE, NEOMYCIN SULFATE | Thompson | de9489de-e677-2bd3-e053-2a95a90acfb4 | 2025-09-08 | Warnings | 057Y626693 |
| Antibiotic Maximum Strength | BACITRACIN ZINC, NEOMYCIN SULFATE, POLYMYXIN B SULFATE | Walgreens | 9a092f24-65b2-4b57-8103-265ea3e03311 | 2025-09-02 | Warnings | 057Y626693 |
| Aerosoothe | TRIPLE ANTIBIOTIC OINTMENT | Aero Healthcare US LLC | 2287a31c-750c-728d-e054-00144ff88e88 | 2025-08-29 | Warnings | 057Y626693 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.